Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-Receives-Positive-EU-CHMP-Opinion-for-KEYTRUDA-pembrolizumab-as-Adjuvant-Treatment-for-Adu-44853985/?utm_source=whatsapp&utm_medium=social&utm_campaign=share